Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients
Sponsor: Balboa Institute of Transplantation
Listed as NCT03438773, this PHASE1 trial focuses on Kidney Transplant Failure and Rejection and Kidney Transplant; Complications and remains ongoing. Sponsored by Balboa Institute of Transplantation, it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Unknown PHASE1
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE1
Status: Unknown Status → Recruiting
-
Sep 2022 — Mar 2023 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Jan 2021 — Sep 2022 [monthly]
Recruiting PHASE1
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2020 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
Aug 2018 — Jun 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Balboa Institute of Transplantation
- California Institute of Renal Research
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .